Value of Life Sciences Innovation
Research Program
Value of Life Sciences Innovation
Program Leadership
Spotlight on PBMs View All
Testimony
Testimony on Competition Issues in the Prescription Drug Supply Chain
Featured Experts: Neeraj Sood
In The News View All
Healthcare Dive
Sood recommends key PBM reforms in testimony before U.S. Senate panel
Featured Experts: Neeraj Sood
CalMatters
California’s proposal to establish fiduciary duty for PBMs would be an important cost-saving reform, Joyce says
Featured Experts: Geoffrey Joyce
Healthcare Brew
Arkansas’ first-in-the-nation law banning PBM ownership of pharmacies should be implemented slowly to ensure access, Qato says
Featured Experts: Dima M. Qato
Modern Healthcare
States are likely to pursue PBM legislation in the absence of federal action, Joyce says
Featured Experts: Geoffrey Joyce
Modern Healthcare
Smaller PBMs are facing challenges gaining market share, Joyce says
Featured Experts: Geoffrey Joyce
Featured Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
Adding a floor price mechanism would protect valuable innovation and effectively give future generations of patients a seat at the negotiating table.
Experts: Darius Lakdawalla
Related Center

Clinical Trial Recruitment Lab (CTRL)
We’re bringing together stakeholders from academia, industry, and philanthropy to test and disseminate innovative recruitment strategies that improve access and representation in clinical trials.
Learn MoreFeatured White Papers View All
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
Experts: Alison Sexton Ward, Karen Van Nuys, Darius Lakdawalla